Navigation Links
GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
Date:3/1/2010

s vaccine research and development activities.  Summarized financial information is attached. Further information concerning the Company's financial position and results of operations are included in its Annual Report on Form 10-K, expected to be filed with the Securities and Exchange Commission on or before March 12, 2010.

"This past year we continued our work toward the advancement of clinical trials, as well as increasing the awareness of our potential vaccine solutions for treating and preventing HIV/AIDS. We are encouraged with our progress on both of these fronts," stated Robert T. McNally, Ph.D., president and chief executive officer.  He continued, "Our technology was further supported by the September 2009 success of a Thailand-based Phase 3 trial for an HIV/AIDS preventative vaccine candidate owned by Sanofi-Aventis and Global Solutions for Infectious Disease, which for the first time elicited both antibody and T cells. Our vaccine compares favorably in that it generates higher frequencies of T cells and better quality antibody. We think that the GeoVax vaccine has the potential to deliver a higher success rate than the 30 percent achieved in the trial in Thailand.

"This disease has infected about one million people in this country alone and it's our aim to be part of the solution.  We have two vaccine clinical programs. One is for the prevention of the disease for those
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. GeoVax Labs, Inc. Plans Public Offering
2. GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
3. FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting
4. GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
5. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
6. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
7. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
8. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
9. GeoVax Reports Progress on Its AIDS Vaccine Technology
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft ... Company,s Phase 2 clinical trial.  This open-label study will ... GPX-150 (an investigational medication), in approximately 30 adults as ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 ...
(Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015  Profil Institute for ... on diabetes and obesity, announced today a new textbook,  ... Development,  published by Springer, a leading global scientific publisher. ... analyze and illustrate techniques for use in early phase ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... Delivering on its Imaging 2.0 commitment to provide ... Electronics (NYSE: PHG, AEX: PHI) today showcased several new ... to deliver the right solution at the right price ... the 97th annual meeting of the Radiological Society of ...
... ALTO, Calif., Nov. 30, 2011 Varian Medical Systems (NYSE: ... scheduled the 2012 Annual Meeting of Stockholders for February 9, 2012 ... be held at the Crowne Plaza Cabana Hotel, 4290 El Camino ... The meeting will be webcast and can be accessed at Varian ...
Cached Medicine Technology:Philips Answers the Call for Worldwide Access to Advanced Imaging Systems for Diagnosis and Treatment 2Philips Answers the Call for Worldwide Access to Advanced Imaging Systems for Diagnosis and Treatment 3Philips Answers the Call for Worldwide Access to Advanced Imaging Systems for Diagnosis and Treatment 4Philips Answers the Call for Worldwide Access to Advanced Imaging Systems for Diagnosis and Treatment 5Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television host, ... 32nd Annual Miami Breast Cancer Conference planned and ... , shares that “a fast-growing, virulent” cancer in her ... not followed up her clean mammogram with an ultrasound. ...
(Date:1/22/2015)... 22, 2015 IsoComforter, Inc. has introduced the ... patented IsoTube design to treat specific body parts and muscle ... progressive and easy to use patented cold therapy machine with ... related orthopedic and muscle injuries. IsoComforter has become the ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... in Africa,s Kalahari Desert lies the "Devil,s claw," a plant ... tendonitis and other illnesses that affect millions each year. Unfortunately, ... so scientists are scrambling to devise new ways to produce ... rare plants. One group of scientists reported a major ...
... all smokeless tobacco users! It,s time to banish the ... they don,t burn and produce inhalable smoke like cigarettes. A ... nicotine, has discovered a single pinch the amount in ... the same amount of another group of dangerous chemicals as ...
... and most expensive patients need fewer health care resources and ... nurse-physician primary care team that tracks their health and offers ... Johns Hopkins Bloomberg School of Public Health. The research, published ... that in the first eight months of a randomized controlled ...
... study in the Aug. 15 issue of the ... use of cognitive behavioral therapy for insomnia (CBT-I) is ... comorbid insomnia. Results showed that treatment improves ... older patients with osteoarthritis and comorbid insomnia without directly ...
... , Air Quality Action ... HARRISBURG, Pa., Aug. 14 The Department of Environmental ... action days for Aug. 15, 16 and 17 in several regions ... the Liberty/Clairton region; Sunday,s is for the Liberty/Clairton, Pittsburgh and Susquehanna ...
... could predict those at risk, expert says, , FRIDAY, Aug. ... of broken bones in older men, says a new study. ... men age 65 and older who had their sex hormone ... that men with low levels of estradiol or high levels ...
Cached Medicine News:Health News:New 'biofactories' produce rare healing substances in the endangered Devil's claw plant 2Health News:New 'biofactories' produce rare healing substances in the endangered Devil's claw plant 3Health News:New study expands the list of hazardous chemicals in smokeless tobacco 2Health News:Guided care reduces cost of health care for older persons with chronic conditions 2Health News:Cognitive behavioral therapy improves sleep and pain in people with osteoarthritis 2Health News:Cognitive behavioral therapy improves sleep and pain in people with osteoarthritis 3Health News:Weekend Weather Prompts Air Quality Advisories 2Health News:Weekend Weather Prompts Air Quality Advisories 3Health News:Sex Hormone Levels Linked to Fractures in Men 2
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
Medicine Products: